Target
Angela Bellini et al.
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Journal of Clinical Oncology 2021, vol. 39, issue 30
doi: 10.1200/jco.21.00086
Angela Bellini et al.
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Journal of Clinical Oncology 2021, vol. 39, issue 30
doi: 10.1200/jco.21.00086
A. Moreira et al.
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery
ESMO Open 2021, vol. 6, issue 4
doi: 10.1016/j.esmoop.2021.100178
A. Moreira et al.
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery
ESMO Open 2021, vol. 6, issue 4
doi: 10.1016/j.esmoop.2021.100178
Paul Gueguen et al.
Contribution of resident and circulating precursors to tumor-infiltrating CD8 + T cell populations in lung cancer
Science Immunology 2021, vol. 6, issue 55
doi: 10.1126/sciimmunol.abd5778
Anne-Céline Derrien et al.
Germline MBD4 Mutations and Predisposition to Uveal Melanoma
JNCI: Journal of the National Cancer Institute 2020, vol. 113, issue 1
doi: 10.1093/jnci/djaa047
Anne-Céline Derrien et al.
Germline MBD4 Mutations and Predisposition to Uveal Melanoma
JNCI: Journal of the National Cancer Institute 2020, vol. 113, issue 1
doi: 10.1093/jnci/djaa047
et al.
Berichtigung
Chemische Berichte 2007, vol. 99, issue 10
doi: 10.1002/cber.19660991046